Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.06 | 16538975 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.42 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.60 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.91 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.91 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.38 | 17967414 16873680 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.63 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.63 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.57 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.58 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.89 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.89 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.89 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
3.29 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.29 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.88 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.98 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.98 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.61 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.20 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.02 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.02 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
10.50 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
10.50 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.48 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.98 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.98 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.87 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.50 | 9664655 17551590 9224671 16925845 8800419 10589399 9125849 14991402 9211117 9142499 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.94 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.14 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.58 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
resveratrol |
7.55 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.03 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.03 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.26 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.23 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.11 | 17923197 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.34 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.34 | 16938888 9664655 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.50 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.50 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
7.88 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.88 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.32 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.86 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.86 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.46 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 16354765 8697196 16959395 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.37 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.21 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.25 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.50 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.91 | 17600658 |
MESH:D007249 |
Inflammation |
|
Bupivacaine |
9.22 | 18165598 |
MESH:D007249 |
Inflammation |
|
resveratrol |
9.22 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.22 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.86 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.63 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.63 | 15992940 17551590 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
6.96 | 19148494 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.96 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
10.49 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
10.49 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
4.30 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.30 | 17596541 16294345 19850784 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.41 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
8.19 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.19 | 19642359 17217047 16935935 9834237 16823087 17368321 17712046 17506722 17361223 16766008 17294898 19029980 19035177 16331271 19075265 12679006 17649720 19225113 17301526 15748426 16788101 16140955 16891316 17339181 17107899 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.36 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
4.80 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.80 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
2.66 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.66 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.52 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
4.04 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.53 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.23 | 11606380 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carmustine |
5.45 | 12393984 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.45 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.58 | 17112576 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.40 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
8.22 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
8.22 | 16490592 17164350 17049120 17935668 14749477 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.16 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
8.07 | 17611569 18720364 17596541 19805378 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
8.07 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.10 | 16525036 16317513 16456233 17125593 17015251 17188708 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.56 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.56 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.04 | 17322642 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.49 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.26 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.32 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.32 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.62 | 17929310 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.48 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Bupivacaine |
6.71 | 18165598 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.52 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
10.56 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.56 | 11399792 11118676 11896295 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
3.69 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.69 | 15767336 17804756 16731767 17636462 17718901 17675339 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.90 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.36 | 16314181 16317513 17058453 15827377 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
9.98 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.98 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.98 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.67 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.18 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
10.57 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.57 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
10.19 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
10.19 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.37 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.56 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |